2M-Closeout

12/05/2021

The Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts.

08/09/2021

https://www.prweb.com/releases/2m_clinical_inc_announces_launch_of_neighborhoodtrials_com_to_connect_pharma_and_biotech_sponsors_with_patients_for_more_effective_and_timely_clinical_trials_recruitment/prweb18114196.htm

ARLINGTON, Texas (PRWEB) August 05, 2021 -- This new platform continues the 2M Clinical mission: to increase participation and retention in clinical trials across all communities by bringing together study-seeking participants, neighborhood organizations, study sponsors, healthcare organizations, an...

11/09/2020

Pfizer this morning announced, "...that the analysis found that the vaccine was more than 90% effective in preventing the disease among trial volunteers who had no evidence of prior coronavirus infection."

https://www.msn.com/en-us/news/us/pfizers-early-data-shows-vaccine-is-more-than-90percent-effective/ar-BB1aPHMB?OCID=ansmsnnews11

10/14/2020

Not only are trials showcasing an underrepresentation of minorities, according to recent studies, we need to OVERREPRESENT.

Contact us today to discuss opportunities for better outcomes in your clinical trials.
Visit https://2mclinical.com/contact/

10/08/2020

In late 2018, a ProPublica article looked at the issue of lack of diversity in cancer drug clinical trials, noting, “Stark under-representation of African Americans is widespread in clinical trials for cancer drugs, even when the type of cancer disproportionately affects them.”

Learn more about our thoughts on the importance on diverse populations in clinical trials here:
https://2mclinical.com/importance-of-diverse-populations-in-clinical-trials/